Dec. 3 at 1:31 AM
$ONMD This one puzzles me. There’s all kinds of recent positive news. FDA clearances, Q3 bookings growth of 815% YOY, 37% in clinical exams, partnership with Palantir, network grew 22%, and they reduced liabilities by 80%. Good tute ownership of 29.81%, insiders own 68% and have been buying like crazy, and low float. Golden cross territory, though still well off the 52 week high and it seems like the situation improved since then. Volume is okay. Too good to be true? I’m planning on picking up some more in the AM.